<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02541682</url>
  </required_header>
  <id_info>
    <org_study_id>TUTF-GOKAEK 2013/50</org_study_id>
    <nct_id>NCT02541682</nct_id>
  </id_info>
  <brief_title>Assessment of the Relationship Between Affective Temperament and the Severity of Nausea and Vomiting in Early Pregnancy</brief_title>
  <official_title>Assessment of the Relationship Between Affective Temperament and the Severity of Nausea and Vomiting in Early Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mustafa Kemalpasa Government Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mustafa Kemalpasa Government Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators aimed to research the relationship between affective
      temperament with the severity of the symptoms of nausea and vomiting in early pregnancy. The
      investigators aimed to assess temperament differences between healthy pregnant women and
      pregnant women suffering from mild, moderate, and severe hyperemesis gravidarum.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TEMPS-A scale measurement</measure>
    <time_frame>1 day</time_frame>
    <description>The participants filled out TEMPS-A survey at their first visit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PUQE scoring index</measure>
    <time_frame>2 months</time_frame>
    <description>The investigators performed this test to subjects three times of session separated by a month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital anxiety and depression scale</measure>
    <time_frame>1 day</time_frame>
    <description>Used for excluding patients with the risk of anxiety disorder or depression.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">252</enrollment>
  <condition>Hyperemesis Gravidarum</condition>
  <condition>Temperament</condition>
  <condition>Morning Sickness</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants who have PUQE ( Pregnancy Unique Quantification of Emesis scoring index) score equal to 3 and showing no symptom of nausea and/or vomiting during the three control visits. Control visits are performed a month apart.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild nausea and vomiting of pregnancy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants who have maximum PUQE ( Pregnancy Unique Quantification of Emesis scoring index) score equal to 4-6 during the three control visits. Control visits are performed a month apart.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate nausea and vomiting of pregnancy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants who have maximum PUQE ( Pregnancy Unique Quantification of Emesis scoring index) score equal to 7-12 during the three control visits. Control visits are performed a month apart.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe nausea and vomiting of pregnancy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants who have maximum PUQE ( Pregnancy Unique Quantification of Emesis scoring index) score equal to 13-15 during the three control visits. Control visits are performed a month apart.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TEMPS-A (Temperament Evaluation of Memphis, Pisa, Paris and San Diego Auto-questionnaire)</intervention_name>
    <description>Participants filled out the TEMPS-A survey at their first visit.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Mild nausea and vomiting of pregnancy</arm_group_label>
    <arm_group_label>Moderate nausea and vomiting of pregnancy</arm_group_label>
    <arm_group_label>Severe nausea and vomiting of pregnancy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To be 16 years or older

          -  To be at the level of education to understand and answer the survey questions

          -  To have singleton live pregnancy within the first six weeks of pregnancy according to
             ultrasound measurement or the level of human chorionic gonadotropine in the blood

          -  Agreed to participate the study by signing a voluntary informed consent form

        Exclusion Criteria:

          -  History of any medical problems (eg. endocrine, gastrointestinal, cardiovascular,
             pulmonary system diseases, vertigo)

          -  Presence of a history of psychiatric disorder (eg. depression, anxiety, bipolar
             disorder, delirium, eating disorders and other psychotic disorders)

          -  Multiple pregnancy

          -  Pregnancy complicating situation (eg. imminent abortion, trophoblastic disease,
             ectopic pregnancy)

          -  Presence of a history of regular medication use (Including drug use within the last
             six months for psychiatric illness)

          -  To be not at the risk for anxiety disorder or depression according to the result of
             hospital anxiety and depression scale
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ALI BAHADIRLI, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Recruiting</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mustafakemalpasa Government Hospital</name>
      <address>
        <city>Bursa</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005 Sep-Oct;11(5):527-39. Epub 2005 Jul 8. Review. Erratum in: Hum Reprod Update. 2007 Mar-Apr;13(2):207.</citation>
    <PMID>16006438</PMID>
  </results_reference>
  <results_reference>
    <citation>Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993 Jun;43(371):245-8. Erratum in: Br J Gen Pract 1993 Aug;43(373):325.</citation>
    <PMID>8373648</PMID>
  </results_reference>
  <results_reference>
    <citation>Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20(2):e171-83. Epub 2013 Jul 13. Review.</citation>
    <PMID>23863575</PMID>
  </results_reference>
  <results_reference>
    <citation>Bashiri A, Neumann L, Maymon E, Katz M. Hyperemesis gravidarum: epidemiologic features, complications and outcome. Eur J Obstet Gynecol Reprod Biol. 1995 Dec;63(2):135-8.</citation>
    <PMID>8903768</PMID>
  </results_reference>
  <results_reference>
    <citation>Fell DB, Dodds L, Joseph KS, Allen VM, Butler B. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol. 2006 Feb;107(2 Pt 1):277-84.</citation>
    <PMID>16449112</PMID>
  </results_reference>
  <results_reference>
    <citation>Flaxman SM, Sherman PW. Morning sickness: adaptive cause or nonadaptive consequence of embryo viability? Am Nat. 2008 Jul;172(1):54-62. doi: 10.1086/588081.</citation>
    <PMID>18500939</PMID>
  </results_reference>
  <results_reference>
    <citation>Weigel RM, Weigel MM. Nausea and vomiting of early pregnancy and pregnancy outcome. A meta-analytical review. Br J Obstet Gynaecol. 1989 Nov;96(11):1312-8.</citation>
    <PMID>2611170</PMID>
  </results_reference>
  <results_reference>
    <citation>Wegrzyniak LJ, Repke JT, Ural SH. Treatment of hyperemesis gravidarum. Rev Obstet Gynecol. 2012;5(2):78-84.</citation>
    <PMID>22866186</PMID>
  </results_reference>
  <results_reference>
    <citation>McCarthy FP, Khashan AS, North RA, Moss-Morris R, Baker PN, Dekker G, Poston L, Kenny LC; SCOPE Consortium. A prospective cohort study investigating associations between hyperemesis gravidarum and cognitive, behavioural and emotional well-being in pregnancy. PLoS One. 2011;6(11):e27678. doi: 10.1371/journal.pone.0027678. Epub 2011 Nov 18.</citation>
    <PMID>22125621</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2015</study_first_submitted>
  <study_first_submitted_qc>September 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2015</study_first_posted>
  <last_update_submitted>November 20, 2015</last_update_submitted>
  <last_update_submitted_qc>November 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mustafa Kemalpasa Government Hospital</investigator_affiliation>
    <investigator_full_name>ALI BAHADIRLI</investigator_full_name>
    <investigator_title>Specialist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Hyperemesis Gravidarum</mesh_term>
    <mesh_term>Morning Sickness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

